a, a N Clinical Trials

A listing of a, a N clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 2486 clinical trials
Featured trial
PET MRI as a Staging Tool for Head and Neck Cancer

To explore the use of PET/MRI in the staging and pretreatment evaluation of patients with head and neck cancer and to compare this modality to standard PET/CT imaging.

Online studies
  • 0 views
  • 29 Nov, 2021
  • 1 location
  • Online study
Featured trial
Salivary Immune/Stress Biomarkers Among Children

Background: The use of easily accessible biomarkers for assessing young patients' health is important. This study's aim is a measuring stress/immune biomarkers in saliva of healthy school-age children and compare subgroups according to age, sex, stress perception in dental pain related to symptomatic irreversible pulpitis (SIP) and symptomatic apical periodontitis …

Accepts healthy volunteers
Online studies
  • 0 views
  • 22 Aug, 2022
  • 1 location
  • Online study
Featured trial
Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)  

The Swiss-Ped-IBrainD is a national patient registry that collects information on diagnosis, symptoms, treatment, and follow-up of pediatric patients with an inflammatory brain disease in Switzerland.

myelitis
optic neuritis
multiple sclerosis
Online studies
neuromyelitis optica
  • 0 views
  • 14 Mar, 2022
  • 1 location
  • Online study
Featured trial
A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine  

The reason for this 12-month, open-label study is to see if the study drug lasmiditan is safe and effective for the intermittent acute treatment of migraine in children aged 6 to 17. The study will last about 12 months and may include up to 7 visits.

acute treatment
migraine in children
migraine
lasmiditan
ly573144
  • 0 views
  • 16 Feb, 2024
  • 165 locations
Featured trial
PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706

This study consists of 2 parts. Part 1 of the study is conducted to evaluate the efficacy, safety, and tolerability of two doses of K0706 compared to placebo in subjects with early Parkinson's Disease who are not receiving dopaminergic therapy. Part 2 is an optional long term extension study for …

  • 0 views
  • 30 Aug, 2023
  • 5 locations
Featured trial
A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer

Patients in this study will be randomly assigned to get either tucatinib or placebo (a pill with no medicine). This is a blinded study, so neither patients nor their doctors will know whether a patient gets tucatinib or placebo.

  • 0 views
  • 16 Nov, 2021
  • 235 locations
Featured trial
Safety, Tolerability, Pharmacokinetics, and Therapeutic Efficacy of SAR441344 in Primary Sjögren's Syndrome (pSjS) (phaethuSA)

The total duration of the study will be 24 weeks (28 weeks including maximum screening duration) for each participant, including a 12-week treatment period and a 12-week follow-up period.

  • 0 views
  • 17 Nov, 2021
  • 28 locations
Featured trial
Consequences of a Maternal-fetal Chikungunya Virus Infection

We would now like to confirm and characterize their impairments using a battery of confirmatory tests around the age of 13.

Accepts healthy volunteers
  • 0 views
  • 14 Mar, 2022
  • 2 locations
Featured trial
A Mobile Application for Telerehabilitation in Parkinson's Disease  

The purpose of this study is to determine if the 9zest app for Parkinson's disease is feasible, safe, and efficacious when used independently by individuals with Parkinson's disease.

brain stimulation
Accepts healthy volunteers
  • 20 views
  • 16 Apr, 2026
  • 1 location
Featured trial
A Study of Neurofeedback for the Treatment of Parkinson's Disease  

This study aims to reveal relationship between brain activities and the symptoms of Parkinson disease when a neurofeedback training was applied for them.

  • 0 views
  • 16 Feb, 2024
  • 1 location